Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001029142-25-000020
Filing Date
2025-02-12
Accepted
2025-02-12 16:57:13
Documents
1
Period of Report
2025-02-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1739397427.html 4  
1 FORM 4 wk-form4_1739397427.xml 4 6884
  Complete submission text file 0001029142-25-000020.txt   8366
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O DYNAVAX TECHNOLOGIES 2929 SEVENTH STREET, SUITE 100 BERKELEY CA 94710
Business Address
Janssen Robert (Reporting) CIK: 0001580849 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34207 | Film No.: 25615775